查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1701316

磺达肝癸钠市场规模、份额、趋势分析报告：按类型、产品、分销管道、地区和细分市场预测，2025 年至 2030 年

Fondaparinux Market Size, Share & Trends Analysis Report By Type (Deep Vein Thrombosis), By Product (Branded, Generic), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

磺达肝癸钠市场的成长与趋势

根据Grand View Research, Inc.的最新报告，到2030年全球磺达肝癸钠市场规模预计将达到9.909亿美元，预计2025年至2030年期间的复合年增长率为6.3%。

磺达肝癸钠主要用于膝关节和髋关节关节重建置换术。 Arixtra 由葛兰素史克集团生产，是磺达肝癸钠的品牌药。该药物的专利于 2002 年到期。这种活性分子的製造非常复杂，因此直到 2011 年才出现学名药的竞争。 Alchemia 和 Apotex 等非专利製造商于 2011 年获得了简化新药认证，并立即开始生产学名药。

磺达肝癸钠是一种抗凝血剂，与低分子量肝素相比，存活率较高。它用于预防深层静脉栓塞症(DVT) 和肺动脉栓塞(PE)，并透过皮下给药。此外，磺达肝癸钠还可降低缺血事件的风险。

预计主要参与企业之间加强合作，透过专利技术获得製造分子的智慧财产权（IPR）将推动成长。例如，2016年7月，雷迪博士实验室有限公司与Alchemia有限公司达成协议，以1,750万美元购买磺达肝癸钠的智慧财产权。 2014 年 9 月，Mylan NV 以 2.25 亿美元的价格从 Aspen Worldwide, Inc. 收购了磺达肝癸钠的品牌药和仿製药。该交易使迈兰公司能够获得两种用于治疗 PE 的学名药之一。

磺达肝癸钠市场报告重点

  • 预计学名药将在 2024 年占据最大的销售份额，达到 52.1%，并在预测期内保持主导地位。
  • 2024 年，深层静脉栓塞症(DVT) 部分将占据市场的大部分份额。
  • 2024年，医院药局将成为磺达肝癸钠的主要通路
  • 北美磺达肝癸钠市场在全球市场中占据主导地位，2024年占最大销售份额，为37.6%。

目录

第一章调查方法与范围

第二章执行摘要

第三章 磺达肝癸钠市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析—波特五力分析
    • PESTLE分析

第四章 磺达肝癸钠市场：类型业务分析

  • 2024年和2030年的类型市场占有率
  • 类型细分仪表板
  • 按类型分類的市场规模、预测和趋势分析（2018-2030 年）
  • 深层静脉栓塞症
  • 肺动脉栓塞

第五章 磺达肝癸钠市场：产品业务分析

  • 2024年及2030年的产品市场占有率
  • 产品细分仪表板
  • 市场规模、预测与趋势分析（按产品，2018-2030 年）
  • 品牌
  • 非专利的

6. 磺达肝癸钠市场：通路业务分析

  • 2024年及2030年分销通路市场占有率
  • 分销通路细分仪表板
  • 按分销管道分類的市场规模、预测和趋势分析（2018-2030 年）
  • 医院药房
  • 零售药局
  • 网路药局

7. 磺达肝癸钠市场：区域、估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 2018-2030年各国情况
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年各国情况
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年各国情况
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 2018-2030年各国情况
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2018-2030年各国情况
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Abbott Laboratories Inc.
    • Alchemia Limited
    • Apotex Inc.
    • GSK plc
    • Lupin Pharmaceuticals, Inc
    • ScinoPharm Taiwan Ltd
    • Dr. Reddy's Laboratories Ltd.
    • Bayer Healthcare AG
    • GlaxoSmithKline
    • Boehringer Ingelheim
    • Sanofi
    • WisMed
    • Kaifeng
    • Mylan
Product Code: 978-1-68038-960-9

Fondaparinux Market Growth & Trends:

The global fondaparinux market size is estimated to reach USD 990.9 million by 2030, registering to grow at a CAGR of 6.3% from 2025 to 2030 according to a new report by Grand View Research, Inc. Fondaparinux is majorly used during knee and hip replacement surgeries. Arixtra, manufactured by GSK group of companies is the branded drug of Fondaparinux. The drug witnessed patent expiry in 2002. As the active molecule is highly complex to manufacture, it faced low generic competition until 2011. Generic manufacturer companies, such as Alchemia Ltd. and Apotex, Inc., received the Abbreviated New Drug Application approval in 2011 and instantly started the production of generic drugs.

Fondaparinux is used as an anticoagulant and shows improved survival compared with low-molecular-weight heparin. It is used for the prevention of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) and is administered subcutaneously. Moreover, Fondaparinux lowers the risk of ischemic events

The increasing collaboration between the key players for acquiring the Intellectual Property Rights (IPRs) in order to manufacture the molecule through patented technology is expected to drive growth. For instance, in July 2016 Dr. Reddy's Laboratories Ltd. entered into an agreement with Alchemia Ltd. to purchase the IPRs of fondaparinux sodium for USD 17.5 million. In September 2014, Mylan N.V. purchased branded and generic versions of fondaparinux sodium from Aspen Global, Inc. for USD 225 million. The deal gave Mylan N.V. access to one of the two generics indicated for the treatment of PE.

Fondaparinux Market Report Highlights:

  • The generic segment accounted for the largest revenue share of 52.1% in 2024 and is expected to maintain its dominance during the forecast period.
  • The Deep Vein Thrombosis (DVT) segment accounted for a leading share of the market in 2024.
  • Hospital pharmacies emerged as the leading distribution channel for fondaparinux in 2024
  • North America fondaparinux market dominated the global market and accounted for the largest revenue share of 37.6% in 2024

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Product
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Fondaparinux Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Fondaparinux Market: Type Business Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Deep Vein Thrombosis
    • 4.4.1. Deep Vein Thrombosis Market, 2018 - 2030 (USD Million)
  • 4.5. Pulmonary Embolism
    • 4.5.1. Pulmonary Embolism Market, 2018 - 2030 (USD Million)

Chapter 5. Fondaparinux Market: Product Business Analysis

  • 5.1. Product Market Share, 2024 & 2030
  • 5.2. Product Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 5.4. Branded
    • 5.4.1. Branded Market, 2018 - 2030 (USD Million)
  • 5.5. Generic
    • 5.5.1. Generic Market, 2018 - 2030 (USD Million)

Chapter 6. Fondaparinux Market: Distribution Channel Business Analysis

  • 6.1. Distribution Channel Market Share, 2024 & 2030
  • 6.2. Distribution Channel Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 6.6. Online Pharmacies
    • 6.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)

Chapter 7. Fondaparinux Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Fondaparinux Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Fondaparinux Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Denmark Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Sweden Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Norway Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Fondaparinux Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. Australia Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. South Korea Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Fondaparinux Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Fondaparinux Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Abbott Laboratories Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Alchemia Limited
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Apotex Inc.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. GSK plc
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Lupin Pharmaceuticals, Inc
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. ScinoPharm Taiwan Ltd
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Dr. Reddy's Laboratories Ltd.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives.
    • 8.5.8. Bayer Healthcare AG
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. GlaxoSmithKline
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Boehringer Ingelheim
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. Sanofi
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives
    • 8.5.12. WisMed
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial Performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic Initiatives
    • 8.5.13. Kaifeng
      • 8.5.13.1. Overview
      • 8.5.13.2. Financial Performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic Initiatives
    • 8.5.14. Mylan
      • 8.5.14.1. Overview
      • 8.5.14.2. Financial Performance
      • 8.5.14.3. Product Benchmarking
      • 8.5.14.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 Global Fondaparinux Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 5 Global Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 6 Global Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 7 North America Fondaparinux Market, By Country, 2018 - 2030 (USD Million)
  • Table 8 North America Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 9 North America Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 North America Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 11 U.S. Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 13 U.S. Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 14 Canada Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 16 Canada Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 17 Mexico Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 18 Mexico Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 19 Mexico Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20 Europe Fondaparinux Market, By Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 22 Europe Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Europe Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 24 UK Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 25 UK Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 26 UK Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 27 Germany Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 28 Germany Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 29 Germany Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30 France Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 31 France Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 32 France Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 33 Italy Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 34 Italy Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 35 Italy Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 36 Spain Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 37 Spain Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 38 Spain Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 39 Denmark Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 40 Denmark Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 41 Denmark Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 42 Sweden Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 43 Sweden Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 44 Sweden Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 45 Norway Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 46 Norway Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 47 Norway Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Fondaparinux Market, By Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 52 Japan Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 53 Japan Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 54 Japan Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 55 China Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 56 China Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 57 China Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58 India Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 59 India Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 60 India Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 61 Australia Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 62 Australia Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 63 Australia Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 64 South Korea Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 65 South Korea Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 66 South Korea Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 67 Thailand Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 68 Thailand Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 69 Thailand Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 70 Latin America Fondaparinux Market, By Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 72 Latin America Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 73 Latin America Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 74 Brazil Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 75 Brazil Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 76 Brazil Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 77 Argentina Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 79 Argentina Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Fondaparinux Market, By Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 84 South Africa Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 86 South Africa Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 90 UAE Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 91 UAE Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 92 UAE Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Fondaparinux Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Type and Product Outlook (USD Million)
  • Fig. 10 Distribution Channel Outlook (USD Million)
  • Fig. 11 Competitive Landscape
  • Fig. 12 Fondaparinux Market Dynamics
  • Fig. 13 Fondaparinux Market: Porter's Five Forces Analysis
  • Fig. 14 Fondaparinux Market: PESTLE Analysis
  • Fig. 15 Fondaparinux Market: Type Segment Dashboard
  • Fig. 16 Fondaparinux Market: Type Market Share Analysis, 2024 & 2030
  • Fig. 17 Deep Vein Thrombosis Market, 2018 - 2030 (USD Million)
  • Fig. 18 Pulmonary Embolism Market, 2018 - 2030 (USD Million)
  • Fig. 19 Fondaparinux Market: Product Segment Dashboard
  • Fig. 20 Fondaparinux Market: Product Market Share Analysis, 2024 & 2030
  • Fig. 21 Branded Market, 2018 - 2030 (USD Million)
  • Fig. 22 Generic Market, 2018 - 2030 (USD Million)
  • Fig. 23 Fondaparinux Market: Distribution Channel Segment Dashboard
  • Fig. 24 Fondaparinux Market: Distribution Channel Market Share Analysis, 2024 & 2030
  • Fig. 25 Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig. 26 Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig. 27 Online Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig. 28 Fondaparinux Market Revenue, By Region
  • Fig. 29 Regional Marketplace: Key Takeaways
  • Fig. 30 Regional Marketplace: Key Takeaways
  • Fig. 31 North America Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Country Dynamics
  • Fig. 33 U.S. Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada Country Dynamics
  • Fig. 35 Canada Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 36 Mexico Country Dynamics
  • Fig. 37 Mexico Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 38 Europe Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 39 UK Country Dynamics
  • Fig. 40 UK Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany Country Dynamics
  • Fig. 42 Germany Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 43 France Country Dynamics
  • Fig. 44 France Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 45 Italy Country Dynamics
  • Fig. 46 Italy Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 47 Spain Country Dynamics
  • Fig. 48 Spain Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 49 Norway Country Dynamics
  • Fig. 50 Norway Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden Country Dynamics
  • Fig. 52 Sweden Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark Country Dynamics
  • Fig. 54 Denmark Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 56 Japan Country Dynamics
  • Fig. 57 Japan Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 58 China Country Dynamics
  • Fig. 59 China Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 60 India Country Dynamics
  • Fig. 61 India Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 62 Australia Country Dynamics
  • Fig. 63 Australia Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea Country Dynamics
  • Fig. 65 South Korea Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 66 Thailand Country Dynamics
  • Fig. 67 Thailand Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 68 Latin America Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil Country Dynamics
  • Fig. 70 Brazil Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 71 Argentina Country Dynamics
  • Fig. 72 Argentina Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 73 MEA Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa Country Dynamics
  • Fig. 75 South Africa Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 76 Saudi Arabia Country Dynamics
  • Fig. 77 Saudi Arabia Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 78 UAE Country Dynamics
  • Fig. 79 UAE Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 80 Kuwait Country Dynamics
  • Fig. 81 Kuwait Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 82 Company Categorization
  • Fig. 83 Company Market Position Analysis
  • Fig. 84 Strategic Framework